Description
Chemical Information of Sermorlin 5mg
- Molecular Formula: C₁₄₉H₂₄₆N₄₄O₄₂S
- CAS Number: 86168-78-7
- Molecular Weight: 3357.88 g/mol
- Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
- Molecular Structure: Refer to Certificate of Analysis for detailed structural information.
Description:
Sermorlin is a synthetic peptide analog of human growth hormone-releasing hormone (GHRH). Extensively studied for its potential role in stimulating endogenous secretion of growth hormone (GH), Sermorlin is frequently utilized in research involving metabolic pathways, anabolic processes, and cellular regeneration. Provided as a lyophilized powder, Sermorlin is suitable for advanced laboratory studies examining growth hormone release mechanisms, metabolic function, and tissue regeneration.
Storage and Handling of Sermorlin 5mg
Store sealed at recommended laboratory freezer temperatures.
Protect from light, moisture, and excessive heat.
Handle using standard laboratory safety procedures to maintain product integrity.
Sermorlin 5mg Product Specifications
Purity: ≥99% (HPLC Verified)
Appearance: White to off-white lyophilized powder
Solubility: Refer to Certificate of Analysis for physicochemical properties
Important Note:
This product is strictly FOR RESEARCH USE ONLY and is intended exclusively for in vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, cosmetic, or dietary supplement, and has not been evaluated by the FDA. This peptide is not intended to diagnose, treat, cure, or prevent any disease. The bodily introduction into humans or animals is strictly prohibited by law. Any misuse, misbranding, or mislabeling is a violation of federal regulations and may result in legal action under applicable federal, state, or local laws.
References:
Referenced scientific publications include:
- Prakash, A., & Goa, K. L. (1999). “Sermorlin: A Review of Its Use in the Diagnosis and Treatment of Growth Hormone Deficiency.” BioDrugs.
- Merriam, G. R., et al. (2001). “Sermororlin and Growth Hormone-Releasing Hormone Analogs in the Management of Aging.” Endocrinology and Metabolism Clinics.
